1Chang K J, Jong SP, Eun JL, et al. Autoinmmune hemolyticanemia in a patient with primary ovarian non-Hodgkin' s lymphoma [J]. J Korean Med Sci,2004,19(2) :294 - 296.
2Chorlton I, Norris HJ, King FM. Malignant retickloendothelial disease Ⅰ nvolving the ovary as a primary manifestation: a series of 19 lymphomas and lgranulocytic sarcoma [J]. Cancer, 1974,34:397 - 407/.
3Fox H, Langley FA Govan ADT, et al. Malignant lymphoma presenting as an ovarian tumor. A etinicopathologicak analysis of 34 cases [J]. Br J Obstet Gynecol, 1988,95(14) :386 - 390.
2Elharroudi T, lsmaili N, Errihani H, et al. Primary lymphoma of the ovary[ J]. J Cancer Res Ther,2008,4:195-196.
3Peetasides D, Iacovidou I, Psyrri A, et al. Primary ovarian lymphoma:report of two eases and review of the literature [J ]. J Chemother, 2008,20 : 513-517.
4Sakurai N, Tateoka K, Taguchi J, et al. Primary precursor β-cell lymphoblastic lymphoma of the ovary:case report and review of the literature [ J ]. Int J Gynecol Pathol, 2008,27:412-417.
7Zacharos ID, Efstathion SP, Petreli E,et al, The prognostic significance of CA125 in patients with non-Hodgkin's lymphoma[ J ]. Eur J Haematol,2002 ,69 :221-226.
8Answer S, Murdoch J, Pawade J, et al. Is the ovary a sanctuary for non-Hodgkin's lymphoma? Successful surgical management[ J]. Br J Hosp Med,2009,70:538-539.
